Robert Klein, Art Torres and Jonathon Thomas. Photo courtesy of the California Stem Cell ReportThe man considered to be the father of the $12 billion California stem cell agency popped up in the news twice this month, once in a $38 million Sacramento lawsuit and then again as the host this month of a Biden campaign fundraiser whose tickets cost as much as $100,000.
Come March 28, Vito Imbascani is scheduled to be sworn in as the new chairman of the $12 billion California stem cell agency – an 18-year-old state program to develop revolutionary treatments for such things as brain and blood cancers, heart disease, diabetes, sickle cell disease, spina bifida, incontinence, blindness, arthritis, HIV, stroke, epilepsy and much more.
A major research facility of the California Institute for Regenerative Medicine at UC Merced. (Photo: CIRM)Two persons with deep ties to the University of California (UC) have been nominated for the position of chair of the governing board of the $12 billion California stem cell agency. They are John A. Pérez, former chair of the UC board of regents and former leader of the state Assembly, and Emilie Marcus, executive strategy officer at the UCLA School of Medicine. It is now up to the 35-member stem cell agency board to choose between the two.
A research scientist examines a capsule with a DNA double helix. (Photo: Dan Race, via Shutterstock)One year ago this month, a $5.5 billion wave washed over California’s ambitious stem cell agency and left it refreshed and renewed for another decade or so of searching for “miraculous” treatments for a host of deadly, incurable afflictions. It is now on a pace to hand out $38,000 an hour, 24 hours a day, seven days a week. That would amount to $519 million in awards between this time last year and the end of the agency’s current fiscal year in June.
An illustration of DNA being injected into a stem cell. (Image: Spectral-Design, via Shutterstock)The folks in Orange Cove in California’s agriculturally rich Central Valley care about the cost of health care. It is part of their struggle each day as they try to live on $27,000 a year, the lowest median household income of any town in the Golden State. Over in Oakland at the headquarters of the $12 billion state stem cell agency, the folks there are also worried about the cost of health care, particularly cell and gene therapies that may well cost upwards of $2 million.
Stem cell research using what's known as a PCR strip. (Image: Science Photo via Shutterstock) California’s ambitious stem cell agency has launched itself on a new, $5.5 billion journey, approving a plan to hand out $182 million to researchers by the middle of next year and beefing up its efforts to bring equality to therapies and scientific labs.
Stem cell research in what is known as a "PCR strip." (Image: Science Photo, via Shutterstock)Legislation to help stem the tide of unregulated stem cell clinics in California is still being drafted, but is expected to be introduced by the end of this month. Art Torres, vice chairman of the California stem cell agency, is working on the measure, which is expected to be authored by Assemblyman Kevin Mullin, D-San Mateo.
House Democratic Caucus Chairman Xavier Becerra, Gov. Brown's pick for state attorney general. (Photo: Bill Clark/CQ Roll Call via AP)Congressman Xavier Becerra, the Democrats’ highest-ranking Latino in the House and a 24-year veteran of Congress, was appointed Thursday by Gov. Brown to replace state Attorney General Kamala Harris, who was elected to the U.S. Senate on Nov. 8. Becerra, 58, who will be the first Latino to serve as California’s top law enforcement officer, will formally take over the attorney general’s office next month, when Harris leaves for Washington, D.C.